Last reviewed · How we verify
NCT05713760
Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults
Phase 2 trial testing Tirbanibulin Ointment 1% in Superficial Basal Cell Carcinoma in 5 participants. Completed in 7 March 2024.
7 March 2024
Quick facts
| Lead sponsor | Austin Institute for Clinical Research |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 5 |
| Start date | 17 April 2023 |
| Primary completion | 7 March 2024 |
| Estimated completion | 7 March 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Tirbanibulin Ointment 1% — full drug profile →
Conditions studied
- Superficial Basal Cell Carcinoma — all drugs for Superficial Basal Cell Carcinoma →
Sponsor
Austin Institute for Clinical Research
Who can join
18 and older, any sex, with Superficial Basal Cell Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a Phase 2, Single-Arm, Open-Label, Single Center, Proof of Concept Study to Assess Efficacy and Safety of Tirbanibulin Ointment 1% in Adult Subjects with superficial basal cell carcinoma (sBCC) on the neck, trunk, or extremities (excluding, axilla, anogenital, and face/scalp).
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Focal adhesion in the tumour metastasis: from molecular mechanisms to therapeutic targets.
Liu Z, Zhang X, Ben T, Li M, et al · · 2025 · cited 12× · PMID 40045379 · DOI 10.1186/s40364-025-00745-7 -
Synthesis and evaluation of tirbanibulin derivatives: a detailed exploration of the structure-activity relationship for anticancer activity.
Park J, Kang M, Lim A, Cho KJ, et al · · 2023 · cited 2× · PMID 38077981 · DOI 10.1039/d3ra06790d
Verify or expand the search:
- PubMed search for NCT05713760
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Superficial Basal Cell Carcinoma
Currently open trials in the same condition.
- NCT04744935 — Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma · NA · active not recruiting
Other Austin Institute for Clinical Research trials
Trials by the same sponsor.
- NCT06376110 — Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Producti · NA · recruiting
- NCT05932732 — Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Ad · Phase 4 · completed
- NCT06090071 — Trial Evaluating Both Tolerability and Improvement for Signs of Facial Photoaging, Discoloration, and Texture in Adult F · Phase 4 · completed
- NCT05908825 — Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in A · NA · completed
- NCT05203315 — Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05713760 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Austin Institute for Clinical Research
- Last refreshed: 19 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05713760.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing